Patents by Inventor Anthony W. Norman

Anthony W. Norman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Therapeutically effective 1&agr;, 25-dihydroxyvitamin D3 analogs and methods for treatment of vitamin D diseases
    Patent number: 6329357
    Abstract: A method for treatment of diseases caused by deficiency or overproduction of the vitamin D3 metabolites by administering analogs of 1&agr;,25-dihydroxyvitamin D3. These analogs are selective agonists or antagonists for the genomic and rapid nongenomic cellular responses. A pharmaceutical composition comprising 1&agr;,25-dihydroxyvitamin D3 analog.
    Type: Grant
    Filed: April 10, 2000
    Date of Patent: December 11, 2001
    Assignee: The Regents of the University of California
    Inventors: Anthony W. Norman, William H. Okamura
  • Therapeutically effective 1&agr;, 25-dihydroxyvitamin D3 analogs
    Patent number: 6307075
    Abstract: Novel analogs of 1&agr;,25-dihydroxyvitamin D3 which are selective agonists for the genomic responses or agonists or antagonists for the rapid cellular responses in a wide array of diseases in which 1&agr;,25-dihydroxyvitamin D3 or its prodrugs are involved. Novel analogs have general formulae represented by compounds of groups I-V. A method for treatment and prevention of diseases connected with the endocrine system.
    Type: Grant
    Filed: November 30, 1999
    Date of Patent: October 23, 2001
    Assignee: The Regents of the University of California
    Inventors: Anthony W. Norman, William H. Okamura
  • THERAPEUTICALLY EFFECTIVE 1ALPHA,25-DIHYDROXYVITAMIN D3 ANALOGS
    Publication number: 20010014749
    Abstract: Novel analogs of 1&agr;,25-dihydroxyvitamin D3 which are selective agonists for the genomic responses or agonists or antagonists for the rapid cellular responses in a wide array of diseases in which 1&agr;,25-dihydroxyvitamin D3 or its prodrugs are involved. Novel analogs have general formulae represented by compounds of groups I-V. A method for treatment and prevention of diseases connected with the endocrine system.
    Type: Application
    Filed: November 30, 1999
    Publication date: August 16, 2001
    Inventors: ANTHONY W. NORMAN, WILLIAM H. OKAMURA
  • Therapeutically effective 1.alpha.,25-dihydroxyvitamin D.sub.3 analogs
    Patent number: 6121469
    Abstract: Novel analogs of 1.alpha.,25-dihydroxyvitamin D.sub.3 which are selective agonists for the genomic responses or agonists or antagonists for the rapid cellular responses in a wide array of diseases in which 1.alpha.,25-dihydroxyvitamin D.sub.3 or its prodrugs are involved. Novel analogs have general formulae represented by compounds of groups I-V. A method for treatment and prevention of diseases connected with the endocrine system.
    Type: Grant
    Filed: May 7, 1998
    Date of Patent: September 19, 2000
    Assignee: The Regents of the University of California
    Inventors: Anthony W. Norman, William H. Okamura
  • Therapeutically effective 1.alpha.,25-dihydroxyvitamin D.sub.3 analogs and methods for treatment of vitamin D diseases
    Patent number: 6103709
    Abstract: A method for treatment of diseases caused by deficiency or overproduction of the vitamin D.sub.3 metabolites by administering analogs of 1.alpha.,25-dihydroxyvitamin D.sub.3. These analogs are selective agonists or antagonists for the genomic and rapid nongenomic cellular responses. A pharmaceutical composition comprising 1.alpha.,25-dihydroxyvitamin D.sub.3 analog.
    Type: Grant
    Filed: May 7, 1998
    Date of Patent: August 15, 2000
    Assignee: The Regents of the University of California
    Inventors: Anthony W. Norman, William H. Okamura
  • 1,25-Dihydroxy-24-oxo-vitamin D.sub.3 and 1,23,25-trihydroxy-24-oxo-vitamin D.sub.3
    Patent number: 4495181
    Abstract: Novel biologically active metabolites of vitamin D.sub.3, 1,23,25-trihydroxy-24-oxo-vitamin D.sub.3 (1,23,25(OH).sub.3 -24-oxo-D.sub.3); and 1,25,-Dihydroxy-24-oxo-vitamin D.sub.3 (1,25(OH).sub.2 -24-oxo-D.sub.3). Also the method of preparing these novel metabolites of vitamin D.sub.3. The use of these compounds in humans for the treatment of disease states involving calcium homeostatic disorders by the administration of an effective amount of said compounds.
    Type: Grant
    Filed: October 3, 1983
    Date of Patent: January 22, 1985
    Assignee: The Regents of the University of California
    Inventors: Anthony W. Norman, Eberhard Mayer
  • 3-Deoxy-1.alpha.-hydroxy- and 3-deoxy-1.alpha.,25-dihydroxycholecalciferol and processes for the preparation thereof
    Patent number: 4264512
    Abstract: Processes for the preparation of 3-deoxy-1.alpha.-hydroxycholecalciferol and 3-deoxy-1.alpha.,25-dihydroxycholecalciferol, novel analogs of cholecalciferol possessing potent intestinal calcium transport stimulatory activity without significant concomitant bone calcium mobilizing activity, are disclosed.
    Type: Grant
    Filed: December 15, 1976
    Date of Patent: April 28, 1981
    Assignee: The Regents of the University of California
    Inventors: William H. Okamura, Anthony W. Norman, Manindra N. Mitra